{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:52:00Z","timestamp":1789059120855,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neonatal hypoxic ischemic encephalopathy (nHIE) is a serious disease that causes severe and chronic neurological damage. Hypothermia therapy improves patients\u2019 outcomes albeit with some limitations, but combining it with treatment with cord blood cells (analogous to mesenchymal stem cells [MSCs]) reportedly improves its effectiveness. TEMCELL HS Inj. (Temcell), a human bone marrow-derived MSC product used for acute graft-versus-host disease, seems an appropriate candidate for this combination therapy. Therefore, we performed a randomized, parallel-group study to compare combined treatment with Temcell and hypothermia versus hypothermia therapy-alone to evaluate the safety and efficacy of Temcell in nHIE patients. The primary endpoint was treatment response defined as an overall developmental quotient of \u2265\u200985 at 18 months of age. Fourteen patients were enrolled and randomized, with 7 assigned to each group. Both groups had similar demographic characteristics and nHIE severity. Treatment response was observed in 4 of the 6 (66.7%) patients in the Temcell combination group, and in 4 of the 7 patients (57.1%) in the hypothermia therapy-alone group. No marked differences in safety profile were observed between the groups. These results indicate that the efficacy of Temcell combined with hypothermia is comparable to therapeutic hypothermia for patients with nHIE.<\/jats:p>\n          <jats:p>Clinical Trial Registration: jRCT1080224818.<\/jats:p>","DOI":"10.1038\/s41598-025-98504-z","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T08:47:34Z","timestamp":1746866854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Combined treatment with mesenchymal stem cells and therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy: a phase 1\/2 randomized trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Kazuko","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kantake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Nishikubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoaki","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Ioroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Mure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihisa","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukimichi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Takasao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kusuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"98504_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fneur.2015.00198","volume":"6","author":"JO Davidson","year":"2015","unstructured":"Davidson, J. O., Wassink, G., van den Heuij, L. G., Bennet, L. & Gunn, A. J. Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy\u2014where to from here?. Front. Neurol. 6, 198. https:\/\/doi.org\/10.3389\/fneur.2015.00198 (2015).","journal-title":"Front. Neurol."},{"key":"98504_CR2","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3390\/ijms17122078","volume":"17","author":"M Zhao","year":"2016","unstructured":"Zhao, M. et al. Oxidative stress in hypoxic-ischemic encephalopathy: Molecular mechanisms and therapeutic strategies. Int. J. Mol. Sci. 17, 2078. https:\/\/doi.org\/10.3390\/ijms17122078 (2016).","journal-title":"Int. J. Mol. Sci."},{"issue":"6 Suppl 1","key":"98504_CR3","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.jped.2015.07.004","volume":"91","author":"RC Silveira","year":"2015","unstructured":"Silveira, R. C. & Procianoy, R. S. Hypothermia therapy for newborns with hypoxic ischemic encephalopathy. J. Pediatr (Rio J.) 91(6 Suppl 1), S78-83 (2015).","journal-title":"J. Pediatr (Rio J.)"},{"key":"98504_CR4","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi, D. V. et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N. Engl. J. Med. 361, 1349\u20131358 (2009).","journal-title":"N. Engl. J. Med."},{"key":"98504_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamapediatrics.2019.4011","volume":"174","author":"M Finder","year":"2020","unstructured":"Finder, M. et al. Two-year neurodevelopmental outcomes after mild hypoxic ischemic encephalopathy in the era of therapeutic hypothermia. JAMA Pediatr. 174, 48\u201355 (2020).","journal-title":"JAMA Pediatr."},{"key":"98504_CR6","doi-asserted-by":"publisher","first-page":"e112339","DOI":"10.1371\/journal.pone.0112339","volume":"9","author":"V Donega","year":"2014","unstructured":"Donega, V. et al. Intranasal administration of human MSC for ischemic brain injury in the mouse: In vitro and in vivo neuroregenerative functions. PLoS ONE 9, e112339. https:\/\/doi.org\/10.1371\/journal.pone.0112339 (2014).","journal-title":"PLoS ONE"},{"key":"98504_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2014.06.009","volume":"261","author":"V Donega","year":"2014","unstructured":"Donega, V. et al. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp. Neurol. 261, 53\u201364 (2014).","journal-title":"Exp. Neurol."},{"key":"98504_CR8","doi-asserted-by":"publisher","first-page":"18587","DOI":"10.1038\/srep18587","volume":"6","author":"Y Gu","year":"2016","unstructured":"Gu, Y. et al. Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by suppressing apoptosis in astrocyte. Sci. Rep. 6, 18587. https:\/\/doi.org\/10.1038\/srep18587 (2016).","journal-title":"Sci. Rep."},{"key":"98504_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1203\/00006450-201011001-00834","volume":"68","author":"CT van Velthoven","year":"2010","unstructured":"van Velthoven, C. T., Kavelaars, A., van Bel, F. & Heijnen, C. J. Nasal administration of stem cells: A promising novel route to treat neonatal ischemic brain damage. Pediatr. Res. 68, 419\u2013422 (2010).","journal-title":"Pediatr. Res."},{"key":"98504_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa032613","volume":"350","author":"SL Staba","year":"2004","unstructured":"Staba, S. L. et al. Cord-blood transplants from unrelated donors in patients with Hurler\u2019s syndrome. N. Engl. J. Med. 350, 1960\u20131969 (2004).","journal-title":"N. Engl. J. Med."},{"key":"98504_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.22670","volume":"71","author":"L Bennet","year":"2012","unstructured":"Bennet, L. et al. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann. Neurol. 71, 589\u2013600 (2012).","journal-title":"Ann. Neurol."},{"key":"98504_CR12","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","volume":"50","author":"ML Levy","year":"2019","unstructured":"Levy, M. L. et al. Phase I\/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke 50, 2835\u20132841 (2019).","journal-title":"Stroke"},{"key":"98504_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CM Cotten","year":"2014","unstructured":"Cotten, C. M. et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J. Pediatr. 164, 973\u2013979 (2014).","journal-title":"J. Pediatr."},{"key":"98504_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12185-015-1915-9","volume":"103","author":"K Muroi","year":"2016","unstructured":"Muroi, K. et al. Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: A phase II\/III study. Int. J. Hematol. 103, 243\u2013250 (2016).","journal-title":"Int. J. Hematol."},{"key":"98504_CR15","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41409-021-01304-y","volume":"56","author":"M Murata","year":"2021","unstructured":"Murata, M. et al. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: Real-world evidence. Bone Marrow Transpl. 56, 2355\u20132366 (2021).","journal-title":"Bone Marrow Transpl."},{"key":"98504_CR16","doi-asserted-by":"publisher","first-page":"724380","DOI":"10.3389\/fimmu.2021.724380","volume":"12","author":"M Murata","year":"2021","unstructured":"Murata, M. & Teshima, T. Treatment of steroid-refractory acute graft-versus-host disease using commercial mesenchymal stem cell products. Front. Immunol. 12, 724380. https:\/\/doi.org\/10.3389\/fimmu.2021.724380 (2021).","journal-title":"Front. Immunol."},{"key":"98504_CR17","unstructured":"Society for the Kyoto Scale of Psychological Development Test. Shinpan K Shiki Hattatsu Kensahou 2001 Nenban [The Kyoto Scale of Psychological Development Test 2001]. (Nakanishiya Shuppan, Kyoto, 2008) (in Japanese)."},{"key":"98504_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1440-1819.2009.01931.x","volume":"63","author":"T Koyama","year":"2009","unstructured":"Koyama, T., Osada, H., Tsujii, H. & Kurita, H. Utility of the Kyoto Scale of Psychological Development in cognitive assessment of children with pervasive developmental disorders. Psychiatry Clin. Neurosci. 63, 241\u2013243 (2009).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"98504_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.6033\/specialeducation.2.17","volume":"2","author":"NSK Tatsuta","year":"2013","unstructured":"Tatsuta, N. S. K., Sugawara, T., Nakai, K., Hosokawa, T. & Satoh, H. Comparison of Kyoto Scale of Psychological Development and Bayley Scales of Infant Development second edition among Japanese. Infant J. Spec. Educ. Res. 2, 17\u201324 (2013).","journal-title":"Infant J. Spec. Educ. Res."},{"key":"98504_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.braindev.2015.10.010","volume":"38","author":"Y Kono","year":"2016","unstructured":"Kono, Y. et al. Developmental assessment of VLBW infants at 18 months of age: A comparison study between KSPD and Bayley III. Brain Dev. 38, 377\u2013385 (2016).","journal-title":"Brain Dev."},{"key":"98504_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jpeds.2015.08.013","volume":"167","author":"S Shankaran","year":"2015","unstructured":"Shankaran, S. et al. Neonatal magnetic resonance imaging pattern of brain injury as a biomarker of childhood outcomes following a trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J. Pediatr. 167, 987\u2013993. https:\/\/doi.org\/10.1016\/j.jpeds.2015.08.013 (2015).","journal-title":"J. Pediatr."},{"key":"98504_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1542\/peds.2006-0325","volume":"117","author":"American Academy of Pediatrics","year":"2006","unstructured":"American Academy of Pediatrics. Committee on Fetus and Newborn; American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. The Apgar score. Pediatrics 117, 1444\u20131447 (2006).","journal-title":"Pediatrics"},{"key":"98504_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archneur.1976.00500100030012","volume":"33","author":"HB Sarnat","year":"1976","unstructured":"Sarnat, H. B. & Sarnat, M. S. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch. Neurol. 33, 696\u2013705 (1976).","journal-title":"Arch. Neurol."},{"key":"98504_CR24","doi-asserted-by":"publisher","first-page":"39508","DOI":"10.1038\/srep39508","volume":"7","author":"K Tsuda","year":"2017","unstructured":"Tsuda, K. et al. Therapeutic hypothermia for neonatal encephalopathy: A report from the first 3 years of the Baby Cooling Registry of Japan. Sci. Rep. 7, 39508. https:\/\/doi.org\/10.1038\/srep39508 (2017).","journal-title":"Sci. Rep."},{"key":"98504_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1055\/s-0039-1693466","volume":"37","author":"A Goenka","year":"2020","unstructured":"Goenka, A., Yozawitz, E., Gomes, W. A. & Nafday, S. M. Selective head versus whole body cooling treatment of hypoxic-ischemic encephalopathy: Comparison of electroencephalogram and magnetic resonance imaging findings. Am. J. Perinatol. 37, 1264\u20131270 (2020).","journal-title":"Am. J. Perinatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98504-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98504-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98504-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T08:47:38Z","timestamp":1746866858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98504-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98504"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98504-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16302"}}